Payment overview · 2025
General Payments
$851.40
3 reported records · 2 companies
Healthcare provider profile · identity verified
James B Bigham, MD
Allopathic & Osteopathic Physicians|Family Medicine · MADISON, WI · NPI 1558595363
Verified facts
What the public records show
CMS Open Payments records show James B Bigham, MD received $851.40 in general payments during 2025 across 3 reported records.
Exact Sciences Corporation accounted for 98.3% of that reported general-payment amount.
The Open Payments records used for this analysis explicitly named 2 associated products.
These records do not establish that a payment influenced prescribing or medical care.
Separate record types
Research & Ownership
Research Payments (direct recipient): not present in the loaded data
Associated Research Funding (for example, named PI): not present in the loaded data
Ownership / Investment: not present in the loaded data
These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.
Who paid this doctor?
Companies in 2025 General Payments
| Reported company | Canonical company | Amount | Share | Records | Year |
|---|---|---|---|---|---|
| Exact Sciences Corporation | Unresolved — no canonical attribution shown | $836.63 | 98.3% | 2 | 2025 |
| Valneva USA, Inc. | Unresolved — no canonical attribution shown | $14.77 | 1.7% | 1 | 2025 |
What were the payments for?
Payment categories
| Category | Amount | Records |
|---|---|---|
| Consulting Fee | $760.00 | 1 |
| Food and Beverage | $91.40 | 2 |
A meal, consulting fee, royalty, and travel payment describe different kinds of reported relationships and should not be interpreted as equivalent.
Analysis 1 · Payment-linked products
Products named in Open Payments records
| Reported product | Type | Reported company | Related amount* | Records | Year |
|---|---|---|---|---|---|
| Cologuard Collection Kit Normalized: cologuard collection kit |
Device | Exact Sciences Corporation | $836.63 | 2 | 2025 |
Source payment records
|
|||||
| IXCHIQ Normalized: ixchiq |
Drug | Valneva USA, Inc. | $14.77 | 1 | 2025 |
Source payment records
|
|||||
* Product-associated amounts are non-additive because one payment record may name more than one product.
These products were named on specific Open Payments records. A named product does not show that the payment influenced treatment or prescribing.
Public prescribing for products named in payments
No exact normalized or approved-alias overlap was found in the loaded Part D year. This does not mean the doctor never prescribed the product.
The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.
Analysis 2 · Same-company prescribing overlap
Drugs reported in other payments from the same company that also appear in Medicare Part D
This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.
No publishable same-company prescribing overlap was found in the loaded Part D year. This does not mean the doctor never prescribed a drug reported elsewhere by a paying company.
These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.
Public Medicare Part D data
Provider-and-drug rows loaded for 2024
| Brand | Generic | Claims | Beneficiaries |
|---|---|---|---|
| Atorvastatin Calcium | Atorvastatin Calcium | 695 | 174 |
| Amlodipine Besylate | Amlodipine Besylate | 465 | 109 |
| Levothyroxine Sodium | Levothyroxine Sodium | 297 | 69 |
| Lisinopril | Lisinopril | 293 | 75 |
| Rosuvastatin Calcium | Rosuvastatin Calcium | 287 | 81 |
| Eliquis | Apixaban | 265 | 46 |
| Hydrochlorothiazide | Hydrochlorothiazide | 258 | 66 |
| Tamsulosin Hcl | Tamsulosin Hcl | 251 | 54 |
| Metoprolol Succinate | Metoprolol Succinate | 218 | 54 |
| Omeprazole | Omeprazole | 218 | 54 |
| Metformin Hcl Er | Metformin Hcl | 187 | 46 |
| Furosemide | Furosemide | 183 | 50 |
| Losartan Potassium | Losartan Potassium | 171 | 43 |
| Gabapentin | Gabapentin | 143 | 37 |
| Carvedilol | Carvedilol | 134 | 27 |
| Sertraline Hcl | Sertraline Hcl | 115 | 33 |
| Trazodone Hcl | Trazodone Hcl | 113 | 32 |
| Metoprolol Tartrate | Metoprolol Tartrate | 111 | 23 |
| Finasteride | Finasteride | 102 | 19 |
| Ozempic | Semaglutide | 97 | 13 |
| Famotidine | Famotidine | 94 | 27 |
| Allopurinol | Allopurinol | 86 | 23 |
| Pantoprazole Sodium | Pantoprazole Sodium | 84 | 27 |
| Valsartan | Valsartan | 82 | 24 |
| Simvastatin | Simvastatin | 81 | 17 |
| Fluoxetine Hcl | Fluoxetine Hcl | 79 | 18 |
| Fluticasone Propionate | Fluticasone Propionate | 78 | 40 |
| Warfarin Sodium | Warfarin Sodium | 78 | 17 |
| Irbesartan | Irbesartan | 77 | 25 |
| Atenolol | Atenolol | 75 | 22 |
| Potassium Chloride | Potassium Chloride | 74 | 21 |
| Benazepril Hcl | Benazepril Hcl | 71 | 22 |
| Lorazepam | Lorazepam | 63 | 31 |
| Jardiance | Empagliflozin | 59 | suppressed |
| Tramadol Hcl | Tramadol Hcl | 59 | 19 |
| Glipizide Er | Glipizide | 57 | 16 |
| Oxycodone Hcl | Oxycodone Hcl | 54 | 13 |
| Hydrocodone-Acetaminophen | Hydrocodone/Acetaminophen | 52 | suppressed |
| Lantus Solostar | Insulin Glargine,hum.Rec.Anlog | 52 | 13 |
| Mirtazapine | Mirtazapine | 50 | 12 |
| Albuterol Sulfate Hfa | Albuterol Sulfate | 49 | 18 |
| Spironolactone | Spironolactone | 45 | suppressed |
| Cyclobenzaprine Hcl | Cyclobenzaprine Hcl | 44 | 21 |
| Clonazepam | Clonazepam | 43 | suppressed |
| Metformin Hcl | Metformin Hcl | 43 | 14 |
| Trulicity | Dulaglutide | 43 | suppressed |
| Zolpidem Tartrate | Zolpidem Tartrate | 43 | 11 |
| Alendronate Sodium | Alendronate Sodium | 41 | 12 |
| Bupropion Xl | Bupropion Hcl | 41 | suppressed |
| Buspirone Hcl | Buspirone Hcl | 40 | suppressed |
| Olanzapine | Olanzapine | 40 | suppressed |
| Clopidogrel | Clopidogrel Bisulfate | 39 | 11 |
| Citalopram Hbr | Citalopram Hydrobromide | 37 | suppressed |
| Lisinopril-Hydrochlorothiazide | Lisinopril/Hydrochlorothiazide | 35 | suppressed |
| Terbinafine Hcl | Terbinafine Hcl | 34 | 11 |
| Xarelto | Rivaroxaban | 33 | suppressed |
| Levetiracetam | Levetiracetam | 32 | suppressed |
| Montelukast Sodium | Montelukast Sodium | 32 | suppressed |
| Prednisone | Prednisone | 32 | 17 |
| Amoxicillin | Amoxicillin | 31 | 13 |
| Doxazosin Mesylate | Doxazosin Mesylate | 31 | suppressed |
| Escitalopram Oxalate | Escitalopram Oxalate | 30 | suppressed |
| Baclofen | Baclofen | 29 | suppressed |
| Pregabalin | Pregabalin | 28 | suppressed |
| Chlorthalidone | Chlorthalidone | 27 | 11 |
| Triamcinolone Acetonide | Triamcinolone Acetonide | 27 | 23 |
| Alprazolam | Alprazolam | 23 | suppressed |
| Amoxicillin-Clavulanate Potass | Amoxicillin/Potassium Clav | 23 | 18 |
| Doxycycline Hyclate | Doxycycline Hyclate | 23 | suppressed |
| Ketoconazole | Ketoconazole | 23 | suppressed |
| Memantine Hcl | Memantine Hcl | 23 | suppressed |
| Nifedipine Er | Nifedipine | 23 | suppressed |
| Duloxetine Hcl | Duloxetine Hcl | 22 | suppressed |
| Novolog Flexpen | Insulin Aspart | 22 | suppressed |
| Oxybutynin Chloride | Oxybutynin Chloride | 22 | suppressed |
| Morphine Sulfate | Morphine Sulfate | 20 | suppressed |
| Nystatin | Nystatin | 20 | suppressed |
| Ultra-Fine Short Pen Needle | Pen Needle, Diabetic | 20 | suppressed |
| Aripiprazole | Aripiprazole | 19 | suppressed |
| Bupropion Hcl | Bupropion Hcl | 19 | suppressed |
| Dilt-Xr | Diltiazem Hcl | 17 | suppressed |
| Dutasteride | Dutasteride | 17 | suppressed |
| Ezetimibe | Ezetimibe | 17 | suppressed |
| Glipizide | Glipizide | 17 | suppressed |
| Methylphenidate Hcl | Methylphenidate Hcl | 17 | suppressed |
| Ondansetron Odt | Ondansetron | 17 | 12 |
| Ursodiol | Ursodiol | 17 | suppressed |
| Valacyclovir | Valacyclovir Hcl | 17 | suppressed |
| Ventolin Hfa | Albuterol Sulfate | 17 | 12 |
| Nano 2nd Gen Pen Needle | Pen Needle, Diabetic | 16 | suppressed |
| Nitrofurantoin Mono-Macro | Nitrofurantoin Monohyd/M-Cryst | 16 | 12 |
| Risperidone | Risperidone | 16 | suppressed |
| Advair Hfa | Fluticasone Propion/Salmeterol | 15 | suppressed |
| Diazepam | Diazepam | 15 | suppressed |
| Pioglitazone Hcl | Pioglitazone Hcl | 15 | suppressed |
| Sumatriptan Succinate | Sumatriptan Succinate | 15 | suppressed |
| Amiodarone Hcl | Amiodarone Hcl | 14 | suppressed |
| Azithromycin | Azithromycin | 14 | suppressed |
| Estradiol | Estradiol | 14 | suppressed |
| Haloperidol | Haloperidol | 14 | suppressed |
| Lansoprazole | Lansoprazole | 14 | suppressed |
| Levetiracetam Er | Levetiracetam | 14 | suppressed |
| Mounjaro | Tirzepatide | 14 | suppressed |
| Verapamil Er | Verapamil Hcl | 14 | suppressed |
| Bromocriptine Mesylate | Bromocriptine Mesylate | 13 | suppressed |
| Carisoprodol | Carisoprodol | 13 | suppressed |
| Ciprofloxacin Hcl | Ciprofloxacin Hcl | 13 | 12 |
| Donepezil Hcl | Donepezil Hcl | 13 | suppressed |
| Glycopyrrolate | Glycopyrrolate | 13 | suppressed |
| Humalog Kwikpen U-100 | Insulin Lispro | 13 | suppressed |
| Incruse Ellipta | Umeclidinium Bromide | 13 | suppressed |
| Januvia | Sitagliptin Phosphate | 13 | suppressed |
| Levocarnitine | Levocarnitine (With Sugar) | 13 | suppressed |
| Nortriptyline Hcl | Nortriptyline Hcl | 13 | suppressed |
| Propranolol Hcl | Propranolol Hcl | 13 | suppressed |
| Cephalexin | Cephalexin | 12 | suppressed |
| Clobazam | Clobazam | 12 | suppressed |
| Fluvoxamine Maleate | Fluvoxamine Maleate | 12 | suppressed |
| Latanoprost | Latanoprost | 12 | suppressed |
| Morphine Sulfate Er | Morphine Sulfate | 12 | suppressed |
| Oxybutynin Chloride Er | Oxybutynin Chloride | 12 | suppressed |
| Quetiapine Fumarate | Quetiapine Fumarate | 12 | suppressed |
| Sulfamethoxazole-Trimethoprim | Sulfamethoxazole/Trimethoprim | 12 | suppressed |
| Topiramate | Topiramate | 12 | suppressed |
| Venlafaxine Hcl Er | Venlafaxine Hcl | 12 | suppressed |
| Asmanex | Mometasone Furoate | 11 | suppressed |
| Diclofenac Sodium | Diclofenac Sodium | 11 | suppressed |
| Gemfibrozil | Gemfibrozil | 11 | suppressed |
| Ondansetron Hcl | Ondansetron Hcl | 11 | suppressed |
| Restasis | Cyclosporine | 11 | suppressed |
| Trelegy Ellipta | Fluticasone/Umeclidin/Vilanter | 11 | suppressed |
Timeline
Payment and prescribing data by year
Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.
| Year | General Payments | Main payer | Explicit products | Company overlaps | Part D coverage |
|---|---|---|---|---|---|
| 2025 | $851.40 · 3 records | Exact Sciences Corporation | Cologuard Collection Kit, IXCHIQ | — | — |
| 2024 | — | — | — | — | Complete |
Questions to ask
Questions you could discuss with your doctor
- Are there reasonable alternatives I should understand when we discuss treatment options?
- How should I interpret the industry-payment records shown here in the context of my care?
These are general questions generated from reviewed templates. They are not personalized medical advice.
Sources and limitations
How to read this page
- Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
- Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
- Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
- Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
- When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.
Loaded source releases
| Dataset | Year | Publication | Source |
|---|---|---|---|
| CMS Open Payments — General Payments | 2025 | 2026-06-30 | Original source |
| Medicare Part D Prescribers by Provider and Drug | 2024 | 2026-05-06 | Original source |
| NPPES Data Dissemination V2 | current / reference data | 2026-08-10 | Original source |
Full methodology · Questions & answers · Report a possible error